Matches in SemOpenAlex for { <https://semopenalex.org/work/W2806741586> ?p ?o ?g. }
- W2806741586 endingPage "306" @default.
- W2806741586 startingPage "301" @default.
- W2806741586 abstract "Oxidized phospholipids (OxPL) are ubiquitous, are formed in many inflammatory tissues, including atherosclerotic lesions, and frequently mediate proinflammatory changes 1 . Because OxPL are mostly the products of non-enzymatic lipid peroxidation, mechanisms to specifically neutralize them are unavailable and their roles in vivo are largely unknown. We previously cloned the IgM natural antibody E06, which binds to the phosphocholine headgroup of OxPL, and blocks the uptake of oxidized low-density lipoprotein (OxLDL) by macrophages and inhibits the proinflammatory properties of OxPL2-4. Here, to determine the role of OxPL in vivo in the context of atherogenesis, we generated transgenic mice in the Ldlr-/- background that expressed a single-chain variable fragment of E06 (E06-scFv) using the Apoe promoter. E06-scFv was secreted into the plasma from the liver and macrophages, and achieved sufficient plasma levels to inhibit in vivo macrophage uptake of OxLDL and to prevent OxPL-induced inflammatory signalling. Compared to Ldlr-/- mice, Ldlr -/- E06-scFv mice had 57-28% less atherosclerosis after 4, 7 and even 12 months of 1% high-cholesterol diet. Echocardiographic and histologic evaluation of the aortic valves demonstrated that E06-scFv ameliorated the development of aortic valve gradients and decreased aortic valve calcification. Both cholesterol accumulation and in vivo uptake of OxLDL were decreased in peritoneal macrophages, and both peritoneal and aortic macrophages had a decreased inflammatory phenotype. Serum amyloid A was decreased by 32%, indicating decreased systemic inflammation, and hepatic steatosis and inflammation were also decreased. Finally, the E06-scFv prolonged life as measured over 15 months. Because the E06-scFv lacks the functional effects of an intact antibody other than the ability to bind OxPL and inhibit OxLDL uptake in macrophages, these data support a major proatherogenic role of OxLDL and demonstrate that OxPL are proinflammatory and proatherogenic, which E06 counteracts in vivo. These studies suggest that therapies inactivating OxPL may be beneficial for reducing generalized inflammation, including the progression of atherosclerosis, aortic stenosis and hepatic steatosis." @default.
- W2806741586 created "2018-06-13" @default.
- W2806741586 creator A5010943802 @default.
- W2806741586 creator A5014220812 @default.
- W2806741586 creator A5014668137 @default.
- W2806741586 creator A5017606355 @default.
- W2806741586 creator A5020020228 @default.
- W2806741586 creator A5020082525 @default.
- W2806741586 creator A5021571178 @default.
- W2806741586 creator A5036422288 @default.
- W2806741586 creator A5037079092 @default.
- W2806741586 creator A5039839135 @default.
- W2806741586 creator A5042447340 @default.
- W2806741586 creator A5045616017 @default.
- W2806741586 creator A5048270591 @default.
- W2806741586 creator A5050968979 @default.
- W2806741586 creator A5063740703 @default.
- W2806741586 creator A5068698124 @default.
- W2806741586 creator A5075655470 @default.
- W2806741586 creator A5079971670 @default.
- W2806741586 creator A5087269715 @default.
- W2806741586 creator A5087685684 @default.
- W2806741586 creator A5091030211 @default.
- W2806741586 creator A5091163677 @default.
- W2806741586 date "2018-06-01" @default.
- W2806741586 modified "2023-10-17" @default.
- W2806741586 title "Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice" @default.
- W2806741586 cites W1539079224 @default.
- W2806741586 cites W1977878140 @default.
- W2806741586 cites W2003798182 @default.
- W2806741586 cites W2007250945 @default.
- W2806741586 cites W2008311655 @default.
- W2806741586 cites W2029040800 @default.
- W2806741586 cites W2033745531 @default.
- W2806741586 cites W2037968073 @default.
- W2806741586 cites W2041981225 @default.
- W2806741586 cites W2052227721 @default.
- W2806741586 cites W2078410616 @default.
- W2806741586 cites W2090777067 @default.
- W2806741586 cites W2095478283 @default.
- W2806741586 cites W2109166221 @default.
- W2806741586 cites W2113168018 @default.
- W2806741586 cites W2116592902 @default.
- W2806741586 cites W2124019799 @default.
- W2806741586 cites W2125661827 @default.
- W2806741586 cites W2126873224 @default.
- W2806741586 cites W2127565475 @default.
- W2806741586 cites W2133053216 @default.
- W2806741586 cites W2134685432 @default.
- W2806741586 cites W2140869639 @default.
- W2806741586 cites W2143951282 @default.
- W2806741586 cites W2148989921 @default.
- W2806741586 cites W2156613610 @default.
- W2806741586 cites W2165436546 @default.
- W2806741586 cites W2167620077 @default.
- W2806741586 cites W2168897708 @default.
- W2806741586 cites W2468517437 @default.
- W2806741586 cites W2547954877 @default.
- W2806741586 cites W2580503967 @default.
- W2806741586 cites W2586892149 @default.
- W2806741586 cites W2621035443 @default.
- W2806741586 cites W2734757492 @default.
- W2806741586 cites W2757854240 @default.
- W2806741586 cites W2765337093 @default.
- W2806741586 cites W2783926804 @default.
- W2806741586 cites W2806824378 @default.
- W2806741586 cites W4252134514 @default.
- W2806741586 doi "https://doi.org/10.1038/s41586-018-0198-8" @default.
- W2806741586 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6033669" @default.
- W2806741586 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29875409" @default.
- W2806741586 hasPublicationYear "2018" @default.
- W2806741586 type Work @default.
- W2806741586 sameAs 2806741586 @default.
- W2806741586 citedByCount "330" @default.
- W2806741586 countsByYear W28067415862018 @default.
- W2806741586 countsByYear W28067415862019 @default.
- W2806741586 countsByYear W28067415862020 @default.
- W2806741586 countsByYear W28067415862021 @default.
- W2806741586 countsByYear W28067415862022 @default.
- W2806741586 countsByYear W28067415862023 @default.
- W2806741586 crossrefType "journal-article" @default.
- W2806741586 hasAuthorship W2806741586A5010943802 @default.
- W2806741586 hasAuthorship W2806741586A5014220812 @default.
- W2806741586 hasAuthorship W2806741586A5014668137 @default.
- W2806741586 hasAuthorship W2806741586A5017606355 @default.
- W2806741586 hasAuthorship W2806741586A5020020228 @default.
- W2806741586 hasAuthorship W2806741586A5020082525 @default.
- W2806741586 hasAuthorship W2806741586A5021571178 @default.
- W2806741586 hasAuthorship W2806741586A5036422288 @default.
- W2806741586 hasAuthorship W2806741586A5037079092 @default.
- W2806741586 hasAuthorship W2806741586A5039839135 @default.
- W2806741586 hasAuthorship W2806741586A5042447340 @default.
- W2806741586 hasAuthorship W2806741586A5045616017 @default.
- W2806741586 hasAuthorship W2806741586A5048270591 @default.
- W2806741586 hasAuthorship W2806741586A5050968979 @default.
- W2806741586 hasAuthorship W2806741586A5063740703 @default.
- W2806741586 hasAuthorship W2806741586A5068698124 @default.
- W2806741586 hasAuthorship W2806741586A5075655470 @default.